Amino acid ionic liquids are green solvents with low toxicities and properties suitable for precombustion CO 2 capture, such as high CO 2 absorption, good thermal stability, and negligible vapor pressure. However, their high viscosities and relatively high costs have hampered their industrial applications. In this work, we systematically studied the amino acid ionic liquid tetrabutylphosphonium glycinate ([P 4444 ][Gly]) and its blends with the low-cost and less viscous cosolvent poly(ethylene glycol) (PEG400). The concentration of the blend solvent was optimized with respect to CO 2 solubility, regeneration efficiency, and cyclic capacity. The solubilities of CO 2 in [P 4444 ][Gly], PEG400, and their blends of four different concentrations were measured experimentally in the temperature range of 60−140 °C and up to a pressure of 17 bar. The results showed that the CO 2 solubility increased with increasing ionic liquid concentration in the blend and decreased with increasing temperature. The optimum CO 2 absorption was determined to occur at 30 wt % of [P 4444 ][Gly] in the blend. The regeneration study of the 30 wt % [P 4444 ][Gly]−70 wt % PEG400 blend for three cycles verified its reusability in the process and confirmed that the reaction between [P 4444 ][Gly] and CO 2 can be reversed at 140 °C. The CO 2 absorption capacity of the blend absorbent was found to be up to a loading of 1.23 mol of CO 2 /mol of absorbent. The parameter fitting of the experimental data using empirical correlations was evaluated, and these correlations were developed in particular to predict the blend solvent of an amino acid ionic liquid−PEG400 system based on the ionic liquid concentration and temperature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.